Description

BSE announces securities shortlisted for Short Term ASM framework effective October 27, 2025, including 14 new securities and 9 securities moving out of the framework.

Summary

BSE has announced the applicability of Short Term Additional Surveillance Measure (ST-ASM) effective October 27, 2025. The circular identifies 14 securities being shortlisted in the ST-ASM Framework, 1 security moving to higher stage ASM, and 9 securities moving out of the framework. The ST-ASM framework involves increased surveillance on securities exhibiting abnormal price movements or trading patterns.

Key Points

  • 14 securities newly shortlisted in Short Term 5/15/30 Days ASM Framework effective October 27, 2025
  • Welcure Drugs & Pharmaceuticals Ltd will continue in ST-ASM but move to higher stage ASM
  • 9 securities are moving out of ST-ASM Framework, including 1 due to inclusion in ESM Framework (Aptus Pharma Ltd)
  • Consolidated list provided showing all securities currently under ST-ASM with their respective stages
  • Securities include a mix of regular stocks and SME scrips

Regulatory Changes

The Short Term ASM framework applies enhanced surveillance measures to securities showing concerning price movements or trading patterns over 5/15/30 day periods. Securities entering this framework face:

  • Enhanced monitoring of trading activity
  • Potential restrictions on trading parameters
  • Graduated stages of surveillance based on continued patterns
  • Possible progression to other surveillance frameworks (ESM, GSM, LT-ASM, Trade for Trade)

Compliance Requirements

  • Trading members must ensure awareness of securities under ST-ASM framework
  • Clients trading in these securities should be informed of the surveillance status
  • Enhanced due diligence may be required for transactions in these securities
  • Members must comply with any additional margin or trading restrictions applicable to ST-ASM securities

Important Dates

  • Effective Date: October 27, 2025 - New ST-ASM classifications take effect

Impact Assessment

Market Impact: Medium - The inclusion of 14 securities in ST-ASM framework will result in enhanced surveillance and potentially reduced liquidity for these stocks. Investors may face higher margin requirements and trading restrictions.

Investor Impact: Investors holding or trading in the 14 newly included securities will need to adjust their trading strategies to account for surveillance measures. The exit of 9 securities from the framework provides relief to those stocks.

Operational Impact: Brokers and trading members need to update their systems and risk management frameworks to reflect the new ST-ASM classifications and communicate changes to affected clients.

Securities Affected

Entering ST-ASM Framework (14 securities):

  • Bhageria Industries Ltd
  • Chandni Machines Ltd
  • Helpage Finlease Ltd
  • Infinity Infoway Ltd
  • Mafatlal Industries Ltd
  • Marc Loire Fashions Ltd
  • One Global Service Provider Ltd
  • Pace E-Commerce Ventures Ltd
  • Raghuvansh Agrofarms Ltd
  • Rajkot Investment Trust Ltd
  • Response Informatics Ltd
  • SBL Infratech Ltd
  • Silicon Rental Solutions Ltd
  • Swati Projects Ltd

Moving to Higher Stage: Welcure Drugs & Pharmaceuticals Ltd

Exiting ST-ASM Framework (9 securities): Includes Aptus Pharma Ltd (moving to ESM Framework), Adeshwar Meditex Ltd, Angel Fibers Ltd, Bonlon Industries Ltd, Getalong Enterprise Ltd, Laddu Gopal Online Services Ltd, Modern Engineering And Projects Ltd, Regent Enterprises Ltd, and UR Sugar Industries Ltd.

Impact Justification

Affects trading parameters for 14 securities entering ST-ASM framework and 9 exiting, impacting liquidity and trading flexibility for investors in these stocks